Prognostic factors affecting early colectomy in patients with moderate to severe ulcerative colitis treated with calcineurin inhibitors

被引:8
|
作者
Ban, Hiromitsu [1 ]
Bamba, Shigeki [2 ]
Nishida, Atsushi [2 ]
Inatomi, Osamu [2 ]
Shioya, Makoto [2 ]
Takahashi, Ken-Ichiro [2 ]
Imaeda, Hirotsugu [2 ]
Murata, Masaki [2 ]
Sasaki, Masaya [3 ]
Tsujikawa, Tomoyuki [4 ]
Andoh, Akira [2 ]
机构
[1] Shiga Univ Med Sci, Div Endoscopy, Otsu, Shiga 5202192, Japan
[2] Shiga Univ Med Sci, Div Gastroenterol, Otsu, Shiga 5202192, Japan
[3] Shiga Univ Med Sci, Div Clin Nutr, Otsu, Shiga 5202192, Japan
[4] Shiga Univ Med Sci, Dept Comprehens Internal Med, Otsu, Shiga 5202192, Japan
关键词
ulcerative colitis; colectomy; calcineurin inhibitors; cyclosporine A; tacrolimus; INFLAMMATORY-BOWEL-DISEASE; NUTRITIONAL INDEX; RESCUE THERAPY; TNF-ALPHA; CYCLOSPORINE; INFLIXIMAB; CYTOMEGALOVIRUS; GUIDELINES; ADULTS; MANAGEMENT;
D O I
10.3892/etm.2016.3341
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Calcineurin inhibitors (CNIs) such as cyclosporine A (CSA) and tacrolimus (FK506) are often used as a second-line drug for steroid-refractory or steroid-dependent patients with ulcerative colitis (UC). The aim of the present study was to determine the prognostic factors for early colectomy. A total of 85 hospitalized patients with UC (CSA, 50 patients; FK506, 35 patients) were enrolled. Colectomy carried out within 60 days of starting CNI therapy was defined as. early colectomy'. To assess the prognostic factors affecting early colectomy, clinical practical variables, including the Onodera-prognostic nutritional index (O-PNI): 10xAlb+0.005x (total lymphocyte count), were analyzed. The results demonstrated that the significant factors predicting early colectomy were i) disease severity, ii) immunomodulator-naive history, iii) lower serum hematocrit, iv) lower serum albumin and v) lower O-PNI. In addition, the significant factors predicting overall colectomy were as follows: i) C7-HRP positivity and ii) >10,000 mg of prednisolone used prior to the initiation of CNI treatment. The combination of hematocrit and O-PNI enhanced the prediction of early colectomy. Clinical variables such as hematocrit and O-PNI were the significant factors predicting colectomy. These results may be used as a guide to predict the outcome of patients with UC in clinical settings.
引用
收藏
页码:829 / 834
页数:6
相关论文
共 50 条
  • [41] Risk Factors and Clinical Outcomes Associated with Cytomegalovirus Colitis in Patients with Acute Severe Ulcerative Colitis
    Lee, Ho-Su
    Park, Sang Hyoung
    Kim, Sung-Han
    Kim, Jihun
    Choi, Jene
    Lee, Hyo Jeong
    Kim, Wan Soo
    Lee, Jeong-Mi
    Kwak, Min Seob
    Hwang, Sung Wook
    Yang, Dong-Hoon
    Kim, Kyung-Jo
    Ye, Byong Duk
    Byeon, Jeong-Sik
    Myung, Seung-Jae
    Yoon, Yong Sik
    Yu, Chang Sik
    Kim, Jin-Ho
    Yang, Suk-Kyun
    INFLAMMATORY BOWEL DISEASES, 2016, 22 (04) : 912 - 918
  • [42] Early Mucosal Healing Predicts Favorable Outcomes in Patients With Moderate to Severe Ulcerative Colitis Treated With Golimumab: Data From the Real-life BE-SMART Cohort
    Bossuyt, Peter
    Baert, Filip
    D'Heygere, Francois
    Nakad, Antoine
    Reenaers, Catherine
    Fontaine, Fernand
    Franchimont, Denis
    Dewit, Olivier
    Van Hootegem, Philippe
    Vanden Branden, Stijn
    Lambrecht, Guy
    Ferrante, Marc
    Hindryckx, Pieter
    Macken, Elisabeth
    Caenepeel, Philip
    Vijverman, Anne
    de Suray, Nicolas
    Dutre, Joris
    Louis, Edouard
    Coenegracths, Jean-Louis
    INFLAMMATORY BOWEL DISEASES, 2019, 25 (01) : 156 - 162
  • [43] Early serum albumin changes in patients with ulcerative colitis treated with tacrolimus will predict clinical outcome
    Ishida, Natsuki
    Miyazu, Takahiro
    Tamura, Satoshi
    Tani, Shinya
    Yamade, Mihoko
    Iwaizumi, Moriya
    Hamaya, Yasushi
    Osawa, Satoshi
    Furuta, Takahisa
    Sugimoto, Ken
    WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27 (22) : 3109 - 3120
  • [44] Cost-Effectiveness Analysis of Vedolizumab Compared With Infliximab in Anti-TNF-α-Naive Patients With Moderate-to-Severe Ulcerative Colitis in China
    Zhou, Ting
    Sheng, Yanan
    Guan, Haijing
    Meng, Rui
    Wang, Zijing
    FRONTIERS IN PUBLIC HEALTH, 2021, 9
  • [45] Treatment patterns among patients with moderate-to-severe ulcerative colitis in the United States and Europe
    Armuzzi, Alessandro
    DiBonaventura, Marco daCosta
    Tarallo, Miriam
    Lucas, James
    Bluff, Daniel
    Hoskin, Benjamin
    Bargo, Danielle
    Cappelleri, Joseph C.
    Quirk, Daniel
    Salese, Leonardo
    PLOS ONE, 2020, 15 (01):
  • [46] Natural history of cytomegalovirus infection in a series of patients diagnosed with moderate-severe ulcerative colitis
    Criscuoli, Valeria
    Rizzuto, Maria Rosa
    Montallbano, Luigi
    Gallo, Elena
    Cottone, Mario
    WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (05) : 633 - 638
  • [47] Risk factors and indications for colectomy in ulcerative colitis patients are different according to patient's clinical background
    Kuriyama, Motoaki
    Kato, Jun
    Fujimoto, Tsuyoshi
    Nasu, Junichirou
    Miyaike, Jiro
    Morita, Takechiyo
    Okada, Hiroyuki
    Suzuki, Seiyuu
    Shiode, Junji
    Yamamoto, Hiroshi
    Shiratori, Yasushi
    DISEASES OF THE COLON & RECTUM, 2006, 49 (09) : 1307 - 1315
  • [48] Changes in the rate of and trends in colectomy for ulcerative colitis during the era of biologics and calcineurin inhibitors based on a Japanese nationwide cohort study
    Uchino, Motoi
    Ikeuchi, Hiroki
    Hata, Keisuke
    Okada, Satoshi
    Ishihara, Soichiro
    Morimoto, Koji
    Sahara, Rikisaburo
    Watanabe, Kazuhiro
    Fukushima, Kouhei
    Takahashi, Kenichi
    Kimura, Hideaki
    Hirata, Keiji
    Mizushima, Tsunekazu
    Araki, Toshimitsu
    Kusunoki, Masato
    Nezu, Riichiro
    Nakao, Sayumi
    Itabashi, Michio
    Hirata, Akira
    Ozawa, Heita
    Ishida, Takashi
    Okabayashi, Koji
    Yamamoto, Takayuki
    Noake, Toshihiro
    Arakaki, Junya
    Watadani, Yusuke
    Ohge, Hiroki
    Futatsuki, Ryo
    Koganei, Kazutaka
    Sugita, Akira
    Higashi, Daijiro
    Futami, Kitaro
    SURGERY TODAY, 2019, 49 (12) : 1066 - 1073
  • [49] Changes in the rate of and trends in colectomy for ulcerative colitis during the era of biologics and calcineurin inhibitors based on a Japanese nationwide cohort study
    Motoi Uchino
    Hiroki Ikeuchi
    Keisuke Hata
    Satoshi Okada
    Soichiro Ishihara
    Koji Morimoto
    Rikisaburo Sahara
    Kazuhiro Watanabe
    Kouhei Fukushima
    Kenichi Takahashi
    Hideaki Kimura
    Keiji Hirata
    Tsunekazu Mizushima
    Toshimitsu Araki
    Masato Kusunoki
    Riichiro Nezu
    Sayumi Nakao
    Michio Itabashi
    Akira Hirata
    Heita Ozawa
    Takashi Ishida
    Koji Okabayashi
    Takayuki Yamamoto
    Toshihiro Noake
    Junya Arakaki
    Yusuke Watadani
    Hiroki Ohge
    Ryo Futatsuki
    Kazutaka Koganei
    Akira Sugita
    Daijiro Higashi
    Kitaro Futami
    Surgery Today, 2019, 49 : 1066 - 1073
  • [50] Extraintestinal manifestations at baseline, and the effect of tofacitinib, in patients with moderate to severe ulcerative colitis
    Rubin, David T.
    Reinisch, Walter
    Greuter, Thomas
    Kotze, Paulo G.
    Pinheiro, Marcia
    Mundayat, Rajiv
    Maller, Eric
    Fellmann, Marc
    Lawendy, Nervin
    Modesto, Irene
    Vavricka, Stephan R.
    Lichtenstein, Gary R.
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2021, 14